Penserra Capital Management LLC Bridge Bio Pharma, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$11.38 - $53.41 $38,976 - $182,929	-3,425 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $1,171 - $1,605	25 Added 0.74%	3,425 $160,000
Q2 2021 Aug 12, 2021	BUY	$46.47 - $63.93 $1,626 - $2,237	35 Added 1.04%	3,400 $207,000
Q1 2021 May 13, 2021	BUY	$55.47 - $72.35 $29,953 - $39,069	540 Added 19.12%	3,365 $207,000
Q4 2020 Feb 12, 2021	BUY	$38.38 - $71.11 $68,278 - $126,504	1,779 Added 170.08%	2,825 $200,000
Q3 2020 Nov 13, 2020	BUY	$27.2 - $42.19 $28,451 - $44,130	1,046 New	1,046 $39,000

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.17B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.